Health Trials

Corticosteroid-refractory Chronic Graft vs. Host Disease

1

Review clinical trials related to Corticosteroid-refractory Chronic Graft vs. Host Disease. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Study of Efficacy and Safety of Ruxolitinib in Chinese Participants With Corticosteroid-refractory Chronic Graft vs. Host Disease

The purpose of the study is to assess the efficacy and safety of ruxolitinib in Chinese adult and pediatric participants aged 12 years or older with corticosteroid-refractory chronic graft vs. host disease (SR-cGvHD).

Participants needed: 50
Trial details
Phase: Phase 4Age: 12-100Biological sex: AllType: InterventionalSponsor: Novartis PharmaceuticalsUpdated: Jun 8, 2026Locations: 22
Eligibility criteria

Signed informed consent must be obtained prior to participation in the study. [+11]

Participants who have received two or more systemic treatments for cGvHD in addi... [+6]

Read more